PeptideDB

Glymidine sodium

CAS No.: 3459-20-9

Glymidine sodium is a sulfonamide hypoglycemic agent which stimulates insulin secretion.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Glymidine sodium is a sulfonamide hypoglycemic agent which stimulates insulin secretion.
molecular weight 331.32
Molecular formula C13H14N3NaO4S
CAS 3459-20-9
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 60 mg/mL (180.54 mM)
References 1. Hardison WG, Wood CA. Importance of bicarbonate in bile salt independent fraction of bile flow. Am J Physiol. 1978 Aug;235(2):E158-64. PubMed PMID: 150796. 2. Losert W, Loge O, Jahn P. [Comparison of the beta-cytotropic effect of glymidine sodium (glycodiazine), glucagon, and isopropylnoradrenaline in rats]. Arzneimittelforschung. 1973 Sep;23(9):1251-60. German. PubMed PMID: 4149442. 3. Loge O, Losert W, Jahn P. [Influence on serum insulin concentration of sodium glymidine (glykodiazine), isopropylnorepinephrine, glucagon and theophylline in Chinese hamsters with spontaneous or streptozotocin-induced diabetes mellitus]. Res Exp Med (Berl). 1973 Jun 19;160(4):292-306. German. PubMed PMID: 4269691. 4. Losert W, Rosenthal K, Jahn P, Sitt R. [Comparative studies on the effect of sodium glymidine, glucagon and isopropylnoradrenaline on insulin secretion in rats]. Naunyn Schmiedebergs Arch Pharmakol. 1970;266(4):397-8. German. PubMed PMID: 4397505.